Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial.
Tomoyuki FujisawaHironao HozumiYosuke KamiyaYusuke KaidaTaisuke AkamatsuHideki KusagayaYasuomi SatakeKazutaka MoriMasashi MikamoHiroyuki MatsudaKoshi YokomuraNaoki KoshimizuMikio ToyoshimaShiro ImokawaHideki YasuiYuzo SuzukiMasato KarayamaKazuki FuruhashiNoriyuki EnomotoYutaro NakamuraNaoki InuiTakafumi SudaPublished in: Respirology (Carlton, Vic.) (2020)
PSL plus TAC treatment may achieve a better short-term PFS rate compared with PSL plus CsA treatment. Further studies must be conducted to evaluate the long-term efficacy and safety of such treatment.